Journal article
Evaluation of the Use of Low-Molecular-Weight Heparin in Neonates
Abstract
Controversies exist over the currently recommended guidelines for the use of low-molecular-weight heparin (LMWH) in neonates. We retrospectively studied 30 neonates treated with LMWH and found a poor therapeutic response to recommended doses as measured by anti-Xa levels. Sixty percent of the study participants required their doses to be increased because of subtherapeutic anti-Xa levels during the initial course of their treatment. The mean …
Authors
Chander A; Nagel K; Wiernikowski J; Paes B; Chan AK
Journal
Clinical and Applied Thrombosis/Hemostasis, Vol. 19, No. 5, pp. 488–493
Publisher
SAGE Publications
Publication Date
September 2013
DOI
10.1177/1076029613480557
ISSN
1076-0296